Natco Pharma chief financial officer P Bhaskara Narayana said that the facility which is worth INR 910m ($17.88m) is ready.
"The actual production in the dedicated multiproduction block will commence by the end of this quarter," Business Line quotes Narayana as saying.
Currently, validation batches are being manufactured at the facility, the news agency reported.